Is dicyclomine safe to prescribe to patients with dementia?

Avoid Dicyclomine in Patients with Dementia

Dicyclomine should be avoided in patients with dementia due to its strong anticholinergic properties that can cause or worsen cognitive impairment, delirium, confusion, and other serious central nervous system effects.

Why This Recommendation

Anticholinergic Burden in Dementia

Dicyclomine is an anticholinergic/antispasmodic agent that inhibits muscarinic receptors throughout the autonomic nervous system. The FDA label explicitly warns that "psychosis and delirium have been reported in sensitive individuals (such as elderly patients and/or in patients with mental illness) given anticholinergic drugs" 1. The label further states that CNS effects include "confusional state, disorientation, amnesia, hallucinations, dysarthria, ataxia, coma, euphoria, fatigue, insomnia, agitation and mannerisms, and inappropriate affect" 1.

Guideline-Based Evidence

The 2019 American Geriatrics Society Beers Criteria, while not specifically listing dicyclomine by name, emphasizes avoiding anticholinergic medications in older adults, particularly those with cognitive impairment 2. The Mayo Clinic polypharmacy guidelines specifically warn about anticholinergic agents causing "cognitive impairment" and note that antipsychotics and other CNS-active drugs with anticholinergic properties should be avoided or tapered in dementia patients 3.

Real-World Evidence

Research demonstrates that more than one in four older adults with dementia use potentially inappropriate anticholinergics 4. Studies show high rates (95-98%) of potentially inappropriate medications in dementia patients, with anticholinergic burden scores significantly elevated 5. The most concerning finding is that anticholinergic medications are frequently prescribed despite their known adverse cognitive effects in this vulnerable population 4.

Specific Risks in Dementia Patients

Central Nervous System Effects

• Delirium and confusion: Can be indistinguishable from dementia progression
• Hallucinations and psychosis: May worsen behavioral symptoms
• Cognitive decline: Anticholinergics directly oppose the mechanism of cholinesterase inhibitors often prescribed for dementia
• Falls risk: Dizziness (40% incidence) and somnolence increase fall risk 1

Geriatric-Specific Concerns

The FDA label mandates that "dicyclomine hydrochloride should be used with caution in elderly who may be more susceptible to its adverse effects" 1. Elderly patients are more likely to experience:

• Decreased renal function (dicyclomine is renally excreted)
• Enhanced sensitivity to anticholinergic effects
• Polypharmacy interactions with other CNS medications

Clinical Decision Algorithm

If a patient with dementia is currently on dicyclomine:

1. Discontinue the medication if possible
2. Evaluate the original indication (irritable bowel syndrome, abdominal cramping)
3. Consider non-anticholinergic alternatives for GI symptoms
4. Monitor for withdrawal effects, though dicyclomine typically does not cause significant withdrawal

If considering dicyclomine for a new indication:

1. Do not prescribe - the risk outweighs benefit in dementia
2. Explore alternative therapies without anticholinergic properties
3. Consider non-pharmacologic interventions first

Important Caveats

Drug Interactions

Patients with dementia are often on cholinesterase inhibitors (donepezil, rivastigmine, galantamine). Dicyclomine's anticholinergic effects directly antagonize these medications, rendering both therapies less effective 3.

Symptom Masking

Anticholinergic-induced cognitive changes may be mistakenly attributed to dementia progression rather than medication side effects, leading to inappropriate escalation of dementia treatments or antipsychotics 6.

Monitoring Challenges

The FDA notes that CNS symptoms "usually resolve within 12 to 24 hours after discontinuation of the drug" 1, but in dementia patients, baseline cognitive status makes it difficult to detect acute changes promptly.

Alternative Approaches

For gastrointestinal symptoms in dementia patients:

• Dietary modifications and fiber supplementation
• Antispasmodics with lower anticholinergic burden (though most have some effect)
• Peppermint oil for IBS symptoms
• Probiotics for functional bowel disorders
• Address underlying causes (constipation, medication side effects)

The evidence consistently supports avoiding dicyclomine in dementia patients due to unacceptable risks of cognitive worsening, delirium, falls, and antagonism of dementia-specific therapies 1, 4, 5.